Skip to main content
Premium Trial:

Request an Annual Quote

NIH to Fund Two-Year High-Risk Studies

NEW YORK (GenomeWeb News) – The National Institutes of Health will give grants of up to $200,000 per year over two years to fund research into new scientific ideas and tools that can "substantially advance" biomedical or clinical research, including genomics technologies research at the National Human Genome Research Institute.

The aim of the Exploratory/Developmental Research Grant Program is to encourage exploratory and developmental research efforts by supporting them in their early stages. These programs could involve high-risk efforts that could lead to a breakthrough in some specific areas.

A breakthrough could involve development of new techniques, agents, methodologies, models, or applications that could have "a major impact" on biomedical, behavioral, or clinical research, according to NIH.

Direct costs for these grants are limited to $275,000 over two years, but the funding is not aimed at supporting projects in areas that are well-established or to support long-term projects.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.